H
H. Jorge Baluarte
Researcher at University of Pennsylvania
Publications - 3
Citations - 292
H. Jorge Baluarte is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Transplantation & Compound heterozygosity. The author has an hindex of 3, co-authored 3 publications receiving 249 citations. Previous affiliations of H. Jorge Baluarte include Children's Hospital of Philadelphia.
Papers
More filters
Journal ArticleDOI
Outcomes in pediatric solid‐organ transplantation
TL;DR: LaRosa C, Jorge Baluarte H, Meyers KEC.
Journal ArticleDOI
Mutations in SLC34A3/NPT2c Are Associated with Kidney Stones and Nephrocalcinosis
Debayan Dasgupta,Mark J. Wee,Monica Reyes,Yuwen Li,Peter J. Simm,Peter J. Simm,Amita Sharma,Karl P. Schlingmann,Marco Janner,Andrew Biggin,Joanna Lazier,Michaela Gessner,Dionisios Chrysis,Shamir Tuchman,H. Jorge Baluarte,Michael A. Levine,Dov Tiosano,Karl L. Insogna,David A. Hanley,Thomas O. Carpenter,Shoji Ichikawa,Bernd Hoppe,Martin Konrad,Lars Sävendahl,Craig F Munns,Craig F Munns,Hang Lee,Harald Jüppner,Clemens Bergwitz +28 more
TL;DR: In this article, a review of clinical and laboratory records of 133 individuals from 27 kindreds, including 5 previously unreported HHRH kindreds and two cases with IH, in which known and novel SLC34A3 mutations (c.1357delTTC [p.F453del]; c.G1369A [p] and c.367delC] were identified.
Journal ArticleDOI
The Clinical Impact of Humoral Immunity in Pediatric Renal Transplantation
Abanti Chaudhuri,Miyuki Ozawa,Matthew J Everly,Ettenger Rb,Vikas R. Dharnidharka,Mark C. Benfield,Robert Mathias,Anthony A. Portale,Ruth A. McDonald,William E. Harmon,David B. Kershaw,V. Matti Vehaskari,Elaine S. Kamil,H. Jorge Baluarte,Bradley A. Warady,Li Li,Tara K. Sigdel,Tara K. Sigdel,Szu-Chuan Hsieh,Szu-Chuan Hsieh,Hong Dai,Hong Dai,Maarten Naesens,J Waskerwitz,Oscar Salvatierra,Paul I. Terasaki,Minnie M. Sarwal,Minnie M. Sarwal +27 more
TL;DR: B antibodies to HLA and MICA antigens appear in approximately 25% of unsensitized pediatric patients, placing them at greater risk for acute and chronic rejection with accelerated loss of graft function.